Le Lézard
Classified in: Health
Subjects: TDS, FVT

BD to Present at the Barclays Global Healthcare Conference



FRANKLIN LAKES, N.J., March 8, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Barclays Global Healthcare Conference on Wednesday, March 14, 2018, at 1:35 p.m. ET.

A live webcast of BD's presentations can be accessed from the BD corporate website at www.bd.com/investors and will be available for replay through Wednesday, March 21, 2018. 

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to better diagnose disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com.

Contact:
Kristen Cardillo, Communications ? 201-847-5657
Monique N. Dolecki, Investor Relations ? 201-847-5378

SOURCE BD (Becton, Dickinson and Company)


These press releases may also interest you

at 09:00
ALPHARETTA, Ga., June 20, 2018 /PRNewswire-PRWeb/ -- ClearStar, the technology and service provider to the background check industry, announces that its ClearMD mobile drug testing solution is now integrated with Abbott Laboratories (formerly Alere),...

at 09:00
SillaJen, Inc., (KOSDAQ:215600), a clinical-stage, biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer, announced the first patient has been enrolled in REN026, the Phase 1b clinical trial of Pexa-Vec...

at 09:00
Abbott  will announce its second-quarter 2018 financial results on Wednesday, July 18, 2018, before the market opens.  The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern), and...

at 09:00
Serialization can be a scary proposition for pharmaceutical manufacturers and packagers, but Reed-Lane has deftly evaded the pitfalls with consulting, technical support and project management from Vantage Solutions. Reed-Lane, a contract packaging...

at 09:00
Beckman Coulter Diagnostics announced today its Sensitive Estradiol assay is now licensed by Health Canada, giving laboratories and clinicians in the country access to the accurate and sensitive diagnostic test that aids in patient reproductive...

at 09:00
On June 21st, join the number one skincare brand in North America1 in their DO GOOD movement to raise $1 million through a 24-hour "selfies-for-good" viral event to raise funds to empower youth. On this day, Rodan + Fields will donate $1 for each...




News published on 8 march 2018 at 16:30 and distributed by: